Glatfelter, GC; Pottie, E; Partilla, JS; Sherwood, AM; Kaylo, K; Pham, DNK; Naeem, M; Sammeta, VR; DeBoer, S; Golen, JA; Hulley, EB; Stove, CP; Chadeayne, AR; Manke, DR; Baumann, MH. Structure–activity relationships for psilocybin, baeocystin, aeruginascin, and related analogues to produce pharmacological effects in mice ACS Pharmacol. Transl. Sci., 11 Nov 2022, 5 (11), 1181–1196. 4.8 MB. https://doi.org/10.1021/acsptsci.2c00177 #4-AcO-NMT MS,NMR,other
4,5-MDO-DMT · 4,5-Methylenedioxy-N,N-dimethyltryptamine
5,6-MDO-DMT · 5,6-Methylenedioxy-N,N-dimethyltryptamine
N-Acetyl-5-methoxytryptamine · Melatonin
5-Formyl-4-HO-DMT · 5-Formyl-4-hydroxy-N,N-dimethyltryptamine · 5-Formylpsilocin
7-Formyl-4-HO-DMT · 7-Formyl-4-hydroxy-N,N-dimethyltryptamine · 7-Formylpsilocin
5-PrOO-T · 5-Propanoyloxytryptamine
5-(Ethoxycarbonyl)tryptamine · 5-Ethoxycarbonyl-T
N-Cyanomethyl-N-methyl-3,4-methylenedioxyamphetamine · MDMCM
N,N-Dimethyltryptophan · DMTP · α-Carboxy-N,N-dimethyltryptamine · α-Carboxy-DMT
1-Pentyl-7-azaindole-COOH
1-Pentyl-6-azaindole-COOH
1-Pentyl-5-azaindole-COOH
1-Pentyl-4-azaindole-COOH
N-Methyl-L-tryptophan methyl ester